Incidence, Prevalence, and Survival of Prostate Cancer

Abstract

Background: The literature on the incidence, prevalence, and survival of prostate cancer reveals a complex interplay of various factors influencing this malignancy. The systematic review by Bell et al. (2020) highlights significant temporal trends and racial disparities in global prostate cancer prevalence, indicating that Black men experience a more aggressive form of the disease compared to their white counterparts. Literature Review: Dietary factors are also critical in understanding prostate cancer risk. (Ismail et al., 2019) argue that high consumption of red and processed meats correlates with increased incidence rates, advocating for dietary modifications as a preventive measure. This dietary perspective is complemented by (Dasgupta et al., 2019), who emphasize the importance of equitable healthcare access and early diagnosis in addressing geographic variations in prostate cancer outcomes. (Wang et al., 2022) provide a broader context by revealing alarming statistics regarding global incidence and mortality rates, highlighting how aging populations and socio-economic growth exacerbate the burden of prostate cancer. (Sekhoacha et al., 2022) further elaborate on these trends, emphasizing the heightened incidence rates among Black men and advocating for improved awareness and screening practices. (Fathollahi et al., 2023) delve into the relationship between prostate cancer prevalence and the Human Development Index (HDI) in Asia, identifying socio-economic factors as significant contributors to mortality rates. This aligns with (G Rao et al., 2023), who conduct a meta-analysis revealing that a lack of awareness significantly contributes to high mortality rates, particularly in developing countries. Conclusion: In conclusion, the reviewed literature collectively illustrates the multifaceted nature of prostate cancer incidence, prevalence, and survival. The critical interplay of cultural, dietary, socio-economic, and geographical factors shapes health outcomes for men at risk of this disease. Addressing these disparities through targeted interventions, educational campaigns, and equitable healthcare access is essential for improving prostate cancer outcomes.